Tag: Spectral AI

Double Bubbler Portfolio Allocation (31st January 2026)

In case anyone is curious this chart shows the current approximate split of our ā€˜more adventurous’ capital allocated to Double Bubbler investments. This was based on closing market prices and…

Spectral AI: Zacks maintains $5 valuation and expects mid-2026 FDA decision

https://scr.zacks.com/news/news-details/2026/MDAI-In-the-Blocks-Ready-to-Go-upon-Mid-Year-Authorization-article/default.aspx The principle new information here for me is greater clarity on average FDA timescales for a decision on Spectral AI’s DeepView system. Notably ā€˜Based on historical data, a De…

Back To Top